Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension
Leopoldo Martín Baiza-Durán, Juan Francisco Llamas-Moreno, Clotilde Ayala-BarajasClinical Research Department, Laboratorios Sophia, SA de CV Guadalajara, Jalisco, MéxicoBackground: The purpose of this study was to evaluate the efficacy and safety of two f...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/538090a0fb964ce79c5882cebf7556a0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|